Connect with us

Technology

Elsevier announces expansion to their flagship clinical decision support solution, ClinicalKey AI

Published

on

New functionality and partnerships make it easier for clinicians to access crucial information at the point of care and log learning credits.

NEW YORK, March 3, 2025 /PRNewswire/ — Elsevier, a global leader in health information and data analytics, has announced further enhancements to ClinicalKey AI, the company’s leading generative AI-powered clinical decision support solution. The new functionality and integrations with strategic partners aim to transform the way healthcare providers access and utilize actionable insights, enhancing patient care and efficiency directly within the clinician’s workflow.

Seamless workflows are crucial for doctors as they enable them to focus more on patient care, reduce time-consuming administrative tasks, and access relevant information efficiently. To serve the needs of busy clinicians, ClinicalKey AI is launching new workflow integrations in the electronic health record (EHR) with Epic[1] and into the health information technology (HIT) space with iPrescribe by DrFirst, along with a new mobile app available for Apple and Android users.

The new EHR integration will streamline workflows, enabling clinicians to switch between Epic’s EHR and ClinicalKey AI without needing to navigate away from patient records. ClinicalKey AI can be found in Connection Hub on Epic Showroom, providing a cohesive experience for clinicians, simplifying the process for accessing essential information at the point of care. A new ClinicalKey AI mobile app will further boost access, enhancing clinicians’ ability to access critical information on the go.

Dr. Barry Wendt, Chief Medical Information Officer at St. Elizabeth Healthcare, a development partner on the Epic EHR integration, said: “Clinicians are working under increasing pressure, treating multiple patients with complex cases, and simplifying access to vital information is paramount. With ClinicalKey AI’s seamless integration with the Epic EHR system, clinicians can easily move between the patient’s EHR and the latest evidence-based content, helping them save valuable time when they’re treating patients at the point of care.”

The collaboration with DrFirst, which has solutions used by more than 450,000 prescribers, adds the power of ClinicalKey AI decision support to the company’s iPrescribe by DrFirst HIT platform. “Each day, prescribers make the most of every moment to take care of their patients, even while traveling between their homes, various offices, and other facilities,” said Colin Banas, M.D., M.H.A., Chief Medical Officer of DrFirst. “Making this world-class, evidence-based research tool available within the iPrescribe by DrFirst app gives healthcare providers across all practice sizes and specialties instant access to AI-powered conversational searches of clinical literature—helping them make informed prescribing decisions from anywhere.”

In addition to these new access-enhancing features, ClinicalKey AI will also enable clinicians to earn, track, and claim Continuing Medical Education (CME) and Maintenance of Certification (MOC) credits directly within the platform. Healthcare professionals will be able to earn CME credits through each clinical query and response interaction, seamlessly integrating learning into their daily workflow.

Furthermore, ClinicalKey AI will support auto-submission of MOC credits to American Boards of eight different specialties (internal medicine, pediatrics, anesthesiology, surgery, pathology, otolaryngology, orthopedic surgery and thoracic surgery). This will make ClinicalKey AI the first AI solution of this kind with this capability.

Omry Bigger, President of Clinical Solutions at Elsevier said: “Healthcare professionals continue to face growing pressures on their time while operating in a fast-moving work environment. Since launching ClinicalKey AI in 2024 as the first Gen-AI solution of its kind, we have continued to expand functionality to support clinicians by streamlining processes, improving access and boosting CME, helping them respond to the challenges they face every day.”

ClinicalKey AI is available in over 50 countries and provides answers from a content set that is specifically curated for point of care questions. It enables access to Elsevier titles such as The Lancet, Goldman-Cecil, as well as non-Elsevier titles and a host of other evidence-based sources. Today’s announcement builds on the expanded partnership with the American College of Cardiology (ACC) announced earlier this year, which made the ACC’s Clinical Practice Guidelines and Expert Consensus Decision Pathways on a range of cardiology topics available on ClinicalKey AI.

You can learn more about ClinicalKey AI on our website, and also at the upcoming 2025 HIMSS Conference in Las Vegas. Join the Elsevier team at booth 3616 and AI Pavilion Kiosk 121-14 to find out more about ClinicalKey AI. You can also hear from Elsevier spokespeople Dr. Amber Featherstone-Uwague (3:10 p.m., March 4) and Dr. Paul “PJ” Helmuth (2 p.m., March 5) at speaking sessions in the AI Pavillion.

About Elsevier
As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy.

Together with the Elsevier Foundation, we work in partnership with the communities we serve to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. 

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com

About iPrescribe by DrFirst
iPrescribe by DrFirst is the industry-leading e-prescribing solution, trusted by healthcare providers throughout the U.S. It enables safe and efficient prescribing of controlled and non-controlled substances anytime, anywhere. Built for mobility and designed to adapt to any workflow, iPrescribe ensures seamless, compliant prescribing across all practice settings. Whether used as a standalone mobile solution or integrated with an EHR, iPrescribe delivers flexibility for in-office and after-hours needs. DrFirst solutions help 100 million patients a year and are used by more than 450,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. To learn more, visit iPrescribe.com and DrFirst.com.

Logo – https://mma.prnewswire.com/media/2628519/5194789/Elsevier_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/elsevier-announces-expansion-to-their-flagship-clinical-decision-support-solution-clinicalkey-ai-302390584.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Ampace Spotlights AI-Ready Battery Solutions for Gigascale Infrastructure at DCW Washington 2026

Published

on

By

WASHINGTON, April 21, 2026 /PRNewswire/ — Ampace, a global leader in advanced lithium-ion battery technology, is participating in Data Center World 2026 at the Walter E. Washington Convention Center (Booth 206), where active visitor engagement reflected growing industry focus on how power infrastructure must evolve for the AI era.

This year, Ampace is showcasing how battery systems are becoming an increasingly important enabler of gigascale AI infrastructure. From cell-level technologies to system-level deployment, spanning applications from commercial and industrial energy storage to UPS systems, Ampace is presenting solutions designed to help data centers manage rising power volatility, improve resilience, and scale more efficiently.

At the center of the showcase is the PU Series, Ampace’s AI-ready battery platform engineered for the increasingly dynamic conditions of modern compute environments. As AI clusters drive 100kW+ rack densities, millisecond-level load spikes, and frequent workload transitions, conventional backup systems are being asked to do far more than emergency support. Ampace’s PU Series is designed to absorb rapid fluctuations, maintain stable output, and support uninterrupted operation under highly variable AI workloads.

A key highlight of Ampace’s presence this week will be its featured TECH TALK session with Eaton on April 22, from 2:30 PM to 3:15 PM (Room 209ABC), titled Powering Gigascale AI: How Advanced Batteries Stabilize Extreme Training Loads.

The session will bring together shared industry perspectives from Aaron Schott, UPS Sales Manager at Ampace, and Jon Hymel, Product Manager at Eaton, two professionals working closely with hyperscale, colocation, enterprise, and mission-critical customers navigating the next wave of AI infrastructure growth.

Together, the speakers will explore how established UPS architectures and advanced lithium battery systems are increasingly working in tandem to meet the operational realities of AI data centers. The discussion will examine how battery technologies can support real-time load balancing, improve reliability, and help operators prepare for the transition from megawatt-scale campuses to gigawatt-scale compute ecosystems.

Their joint appearance reflects a growing alignment across the power infrastructure ecosystem: scalable AI requires not only more electricity, but smarter coordination between UPS systems, energy storage, and facility operations. As data centers evolve, battery-enabled continuity is becoming a shared priority across technology providers, operators, and infrastructure partners.

Built for demanding AI applications, Ampace’s platform is engineered to respond rapidly during ramp-up and ramp-down events, while maintaining stable operation under continuous partial-load cycling. Its semi-solid cell technology further enhances intrinsic safety by reducing leakage risk and lowering thermal runaway gas generation, while cabinet-level validation under UL 9540A standards reinforces readiness for mission-critical deployments.

At Ampace’s booth, visitors have been exploring how advanced battery systems can help reduce infrastructure oversizing, relieve pressure on grid connections, and improve continuity in facilities originally designed for steady-state demand. The strong response reflects a broader market shift: batteries are no longer viewed only as standby assets, but as active components of modern AI power architecture.

Visit Booth 206 to meet the Ampace team, experience the PU Series on site, and join in-depth discussions on how advanced battery solutions are helping build a more resilient, scalable, and efficient AI infrastructure. On-site specialists are available throughout the show for live demonstrations, technical briefings, and media inquiries.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ampace-spotlights-ai-ready-battery-solutions-for-gigascale-infrastructure-at-dcw-washington-2026-302749593.html

SOURCE Ampace

Continue Reading

Technology

TÜV Rheinland Opens Advanced Automotive Component Testing Laboratory in Manesar, Haryana

Published

on

By

Empowering automotive industry capabilities through precision testing, international compliance, and innovative solutions for next-generation mobility.

MANESAR, India, April 22, 2026 /PRNewswire/ — TÜV Rheinland, a global leader in independent testing, inspection and certification services, today announced the opening of its state-of-the-art Automotive Component Testing Laboratory (ACT Lab) in Manesar, Haryana. The ACT Lab will support manufacturers in meeting evolving regulatory requirements, adopting emerging technologies, and accelerating time-to-market.

As the world’s third-largest mobility market, India is developing rapidly, and demand for trustworthy, globally recognized testing services continues to rise. TÜV Rheinland’s ACT Lab supports the development of safer and high-performance automotive products.

Strategically located in Manesar, the facility is well-positioned to unlock growth opportunities within India’s automotive and electric mobility ecosystem, while advancing next-generation transport solutions.

Technological Excellence and Advanced Capabilities

The ACT Lab is equipped with advanced testing systems from leading international manufacturers, ensuring precision, reliability, and global acceptance of results.

Its capabilities include structural testing, corrosion and durability assessments, and environmental simulation under extreme conditions. The facility also offers fatigue and lifecycle testing for critical automotive components, alongside comprehensive material analysis for metals and polymers, delivering deep insights into performance under real-world conditions.

By providing end-to-end testing, inspection, and certification solutions under one roof, the lab distinguishes itself through its ability to replicate operational environments, meet global and OEM standards, and deliver highly reliable, traceable results.

Platform for Collaboration, Innovation, and Trust

Commenting on the inauguration, Dr. Matthias Schubert, Executive Vice President Mobility at TÜV Rheinland Group, said: “Our investment in the Automotive Component Testing Laboratory in Manesar reflects TÜV Rheinland’s long-term strategic commitment to India as a key growth market. As the mobility sector undergoes rapid transformation, this facility enables us to support manufacturers with advanced testing capabilities that not only ensure compliance but also drive innovation, safety, and global competitiveness.”

Highlighting the broader strategic intent, Thomas Quernheim, Senior Vice President Mobility, TÜV Rheinland Group, said, “India represents one of the most dynamic opportunities within our global mobility portfolio. This investment reflects our vision to build resilient, future-oriented capabilities that not only respond to market evolution but also shape the standards of tomorrow’s mobility ecosystem.”

Rajendra Kisanrao Bandal, Vice President, Mobility at TÜV Rheinland India, added: “This facility goes beyond a conventional testing laboratory – it is a platform for collaboration and innovation. Combining global expertise with local insight, it enables manufacturers to enhance quality, reliability, and performance, while strengthening India’s position in the global mobility landscape.”

About TÜV Rheinland:

TÜV Rheinland is a leading provider of testing and inspection services worldwide. For over 150 years, the company has helped make the world a safer place. Today, more than 28,000 employees test, inspect and certify products, plants and processes, while also providing training for people in a wide range of professions. Operating from 500 locations in more than 50 countries, TÜV Rheinland helps safeguard key areas of business and everyday life. Headquartered in Cologne and generating annual revenue of close to €3 billion, the company plays a key role in quality assurance worldwide. TÜV Rheinland has been a member of the UN Global Compact since 2006, demonstrating its commitment to anti-corruption and sustainability.

Website: Click here

Media Contact:

Samrat Sinha
Communications & PR
TÜV Rheinland
Email: Samrat.Sinha@ind.tuv.com

Photo – https://mma.prnewswire.com/media/2961708/Manesar_Lab_Pic_Edited_Without_Barbed_Wire.jpg

View original content:https://www.prnewswire.com/in/news-releases/tuv-rheinland-opens-advanced-automotive-component-testing-laboratory-in-manesar-haryana-302748539.html

Continue Reading

Technology

EZVIZ joins the United Nations Global Compact, starting a new chapter of its unwavering journey to long-term sustainability and further expanding its contribution to key environmental issues

Published

on

By

HOOFDDORP, Netherlands, April 22, 2026 /PRNewswire/ — EZVIZ, an advocate for greener smart homes, is proud to announce its participation in the United Nations Global Compact (UNGC) in the International Year of Volunteers for Sustainable Development on this Earth Day. As a smart home pioneer joining the world’s largest corporate sustainability initiative, EZVIZ will align its award-winning EZVIZ Green initiative with the UNGC’s Ten Principles, making a transformative impact through responsible business in environmental protection.

The UN Global Compact is a call to companies to adopt ten universal principles in human rights, labour, environment and anti-corruption, and to support the Sustainable Development Goals (SDGs). With over 25,000 participants across 167 countries, the UNGC is keeping the earth green and clean with its growing influence.

Though new to the initiative, EZVIZ has been implementing SDGs in its development, operations and management, including establishing an ESG committee directed by the Board. On April 10, the company published its 2025 ESG report under its commitment “Our Planet. Our Actions” for transparency and awareness. Over the past year, EZVIZ has received international recognition like the European Green Awards, the SEAL Sustainability Business Awards, and the Indigo Design Award with the “Design for Social Change” honor.

To safeguard a green planet, EZVIZ has addressed land degradation, global warming, plastic recycling, community empowerment and more. Partnering with Treedom, EZVIZ has planted 4,190 trees with local farmers, reducing approximately 738.2 tons of CO2. Together with Plastic Bank, EZVIZ has prevented over 1,000,000 plastic bottles from polluting vulnerable environments. The partnerships are reinforced by internally recycling plastics and minimizing waste. In 2025, EZVIZ incorporated over 30 tons of recycled materials into its RE7 Edge robot vacuum’s design and reduced CO2 emissions by 73.1 tons through greener packaging.

“Becoming part of the UNGC is a significant milestone for us. It means our efforts in building a better planet, have been recognized globally,” said Jingwen Cao, EZVIZ Board Secretary and Director of the ESG Committee. “This participation provides us the confidence to further expand our environmental protection, as well as to set stricter boundaries to avoid sacrificing the environment for commercial gain.”

With green in its brand gene, the company has also developed green technology with a low carbon footprint. The AOV low-energy consumption tech, and the ColorFULL low-light night vision mode help reduce energy consumption and light pollution resulted from 24/7 home security. Firstly embedding self-patented wild animal detection in outdoor cameras, EZVIZ continues to implement responsible AI to balance human safety and wildlife protection, according to Sophie Zhang, EZVIZ Global Brand Director.

“We believe in the power of technology and always strive to benefit not only our users, but also everyone and every life,” said Zhang. “Alongside other industry leaders in the UNGC, EZVIZ is motivated to contribute to a better future for generations to come.”

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/ezviz-joins-the-united-nations-global-compact-starting-a-new-chapter-of-its-unwavering-journey-to-long-term-sustainability-and-further-expanding-its-contribution-to-key-environmental-issues-302745969.html

SOURCE EZVIZ

Continue Reading

Trending